Profile: Cepheid AB provides diagnostic tools for treatment success and improved health economy. Our products are aspergillus tracer, BKV trender, CMV trender,Cp/Mp tracer, EBV trender, HBV trender, HSV 1/2 tracer and VZV tracer. Our aspergillus tracer is an in vitro diagnostic assay that utilizes real-time polymerase chain reaction (PCR) amplification for the qualitative determination of aspergillus spp DNA in human clinical samples. It is intended for the detection of aspergillus spp DNA in human whole blood and plasma samples. Our CMV trender allows for correct monitoring of viral load from whole blood and plasma with high sensitivity and wide dynamic range utilizing real-time PCR detection on three different platforms. Our VZV tracer is a panel member of affigene® assays for the detection of herpes viruses. The kit utilizes real-time polymerase chain reaction (PCR) amplification for the qualitative determination of varicella zoster virus (VZV) DNA in human clinical samples. It is intended for the detection of VZV DNA in vesicle swabs stored in different media and CSF samples.

The company has revenues of USD 5-10 Million, has ~60 employees and is ISO 9001, ISO13485 certified.

FDA Registration Number: 3009613136
US Agent: Yi-ping Lin / Cepheid
Phone: +1-(978)-317-9606  E-Mail: